Off the wire
Xinhua China news advisory -- June 3  • Garden festival kicks off in Ireland, attracts residents, visitors  • Venezuela sends aid to Cuba after tropical storm Alberto  • Venezuela prepares list of political opponents to be freed from jail  • JSE edges weaker as firmer South African rand pulls down mines  • JSE closes lower as U.S. dollar continues to gain  • JSE closes higher buoyed by banks and general retailers  • Microsoft eyes establishing software start-up in Turkey  • Chinese mainland claims 6 of world's top 100 universities in latest THE rankings  • U.S.-EU trade war could "devastate" Irish whiskey industry: IWA  
You are here:   News/

Progress made in the development of hyperthyroidism vaccine

Xinhua,August 01, 2019 Adjust font size:

The rhesus hyperthyroid model successfully proved the hyperthyroidism vaccine is effective, which laid a solid foundation for the research of hyperthyroidism vaccines as well as the prevention of hyperthyroidism.

After four years of research, researchers from the first affiliated hospital of Xi'an Jiaotong University successfully produced the rhesus hyperthyroid model whose symptoms are similar to humans with hyperthyroidism.

They also found that injecting vaccines to the rhesus monkey when it is just born could reduce its incidence of hyperthyroidism. Via the comparative experiment, they proved that vaccines can prevent primates from hyperthyroidism, and the prevention rate was over 90 percent.

Since rhesus monkeys have similar physiological and pathological processes and immune responses to humans, they can prove whether the vaccine is safe and effective or not.

According to the Journal of Endocrinology, hyperthyroidism is an autoimmune disease. The incidence of hyperthyroidism is as high as one percent and the rate of females is up to 1.9 percent. Exploring new prevention and treatment methods of hyperthyroidism, especially the development of hyperthyroidism vaccines, has always been a major project in the field of endocrinology.